Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
29
1
3
4
5
7
8
10
11
12
15
16
17
18
19
21
24
25
26
27
30
31
1
2
A Behavioral Health Collision At The EHR Intersection
2014-09-30    
2:00 pm - 3:30 pm
Date/Time Date(s) - 09/30/2014 2:00 pm Hear Why Many Organizations Are Changing EHRs In Order To Remain Competitive In The New Value-Based Health Care Environment [...]
Meaningful Use and The Rise of the Portals
2014-10-02    
12:00 pm - 12:45 pm
Meaningful Use and The Rise of the Portals: Best Practices in Patient Engagement Thu, Oct 2, 2014 10:30 PM - 11:15 PM IST Join Meaningful [...]
Adva Med 2014 The MedTech Conference
2014-10-06    
All Day
Adva Med 2014 The MedTech Conference October 6-8, 2014 McCormick Place Chicago, IL For more information, visit, advamed2014.com For Registration details, click here  
Public Health Measures Meaningful Use
2014-10-09    
12:00 pm - 12:45 pm
Public Health Measures Meaningful Use: Reporting on Public Health Measures Join Meaningful Use expert Jim Tate for a three part series of webinars addressing MU [...]
2014 Hospital & Healthcare I.T. Conference
2014-10-13    
All Day
Join us at our 2014 Hospital & Healthcare I.T. Conference and experience the following: Up to 125 Hospital & Healthcare I.T. executives from America’s most prestigious [...]
Connected Health Care 2014
Key Trends That will be Discussed at the Conference! Connected Healthcare 2014 is set to explore the crucial topics that are revolutionizing the connected health industry: [...]
HealthTech Conference
2014-10-14    
All Day
HealthTech Capital is a group of private investors dedicated to funding and mentoring new "HealthTech" start ups at the intersection of healthcare with the computer [...]
Health Informatics & Technology Conference (HITC-2014)
2014-10-20    
All Day
Information technology has ability to improve the quality, productivity and safety of health care mangement. However, relatively very few health care providers have adopted IT. [...]
HIMSS Amsterdam 2014
2014-10-20    
12:00 am
About HIMSS Amsterdam 2014 This year, the second annual HIMSS Amsterdam event will be taking place on 6-7 November 2014 at the Hotel Okura. The [...]
Patient Portal Functionality and EMR Integration Demonstration
2014-10-22    
2:00 pm - 3:30 pm
This purpose of this webcast is to present a demonstration to show how the Patient Portal integrates with EMR, as well as discuss how this [...]
Connected Health Symposium 2014
Symposium 2014 - Connected Health in Practice: Engaging Patients and Providers Outside of Traditional Care Settings Collaborating with industry visionaries, clinical experts, patient advocates and [...]
CHIME College of Healthcare Information Management Executives
2014-10-28 - 2014-10-31    
All Day
The Premier Event for Healthcare CIOs Hotel Accomodations JW Marriott San Antonio Hill Country 23808 Resort Parkway San Antonio, Texas 78761 Telephone: 210-276-2500 Guest Fax: [...]
The Myth of the Paperless EMR
2014-10-29    
2:00 pm - 3:00 pm
Is Paper Eluding Your Current Technologies; The Myth of the Paperless EMR Please join Intellect Resources as we present Is Paper Eluding Your Current Technologies; The Myth [...]
Events on 2014-09-30
Events on 2014-10-02
Events on 2014-10-06
Events on 2014-10-09
Events on 2014-10-13
Events on 2014-10-14
Connected Health Care 2014
14 Oct 14
San Diego
HealthTech Conference
14 Oct 14
San Mateo
Events on 2014-10-20
HIMSS Amsterdam 2014
20 Oct 14
Amsterdam
Events on 2014-10-23
Events on 2014-10-28
Events on 2014-10-29
Latest News

Factors Predicting Poor Locoregional Control in Tongue Cancer

In patients with pT1-2N0 oral tongue squamous cell carcinoma undergoing partial glossectomy and elective neck dissection, inferior locoregional control (LRC) was associated with depth of invasion, lymphovascular space invasion, and positive glossectomy specimen margins. These retrospective findings, presented at the 2024 ASTRO Multidisciplinary Head and Neck Cancers Symposium, remained significant even in cases with final negative tumor bed margins.At a median follow-up of 45.6 months, the all-comer patient population exhibited 3-year locoregional control (LRC) and overall survival (OS) rates of 88.0% and 92.5%, respectively. Among patients with pT1 disease, these rates were 92.0% and 95.2%, while in those with pT2 disease, the rates were 85.0% and 90.5%.

However, during the multivariate analysis, individuals with positive glossectomy margins exhibited poorer locoregional control (HR, 6.66; 95% CI, 1.60-27.78; P = .009). Lymphovascular space invasion (HR, 6.90; 95% CI, 1.42-33.65; P = .02) and depth of invasion (HR, 1.31; 95% CI, 1.06-1.63; P = .01) were also correlated with diminished locoregional control.

The lead study author, Michael Modzelewski, MD, along with the co-investigators, stated in a poster presented at the meeting, “Patients with these risk factors may be considered for adjuvant radiotherapy to optimize disease control.”

Individuals with early-stage tongue squamous cell carcinoma typically do not undergo adjuvant radiation due to their low recurrence risk. After surgery, the status of the primary glossectomy specimen margin has been observed to have a stronger correlation with local recurrence than the status of additional tumor bed margins, as stated by the authors.

The investigators aimed to identify the pathological factors associated with locoregional recurrence in patients with early-stage tongue squamous cell carcinoma who underwent surgery alone. Additionally, they explored the impact of a positive glossectomy specimen margin on disease control concerning final negative tumor bed margins.

The research included 110 patients diagnosed with pT1-2N0 oral tongue squamous cancer, adhering to the American Joint Committee on Cancer (AJCC) 8th edition criteria. These individuals underwent partial glossectomy and elective dissection from 2015 to 2021, excluding adjuvant radiation. Pathology reports were examined for factors such as tumor size, depth of invasion, glossectomy specimen margin, final tumor bed margin status, and perineural or lymphovascular space invasion. Individuals with positive final margins or a history of head and neck radiation were excluded.

The Kaplan-Meier method was employed to estimate locoregional control (LRC) and overall survival (OS), with a Cox proportional hazards model identifying prognostic factors for LRC in multivariate analysis.

Concerning baseline characteristics, the median age was 52 years, with the majority being male (54.5%) and having pT2 stage disease (58.2%). There were 33 lymph nodes dissected on average, and the median tumor size measured 16 mm, with a depth of invasion reaching 5 mm.

The majority of patients did not exhibit perineural invasion (84.7%), while 3.6% had lymphovascular space invasion. Positive glossectomy specimen margins were observed in 8.2% of cases.

Further findings revealed that among patients with positive glossectomy specimen margins and those without, the 3-year locoregional control (LRC) rates were 66.7% and 89.5%, respectively. Similarly, the rates were 0.0% for individuals with lymphovascular space invasion and 89.4% for those without. Among the 8 patients experiencing regional failure, 5 had recurrence in the ipsilateral neck alone (62.5%), 2 in the bilateral neck (25.0%), and 1 with isolated contralateral neck recurrence (12.5%).